Mermoud A, Schnyder C C, Sickenberg M, Chiou A G, Hédiguer S E, Faggioni R
Hôpital Ophtalmique Jules Gonin, Lausanne, Switzerland.
J Cataract Refract Surg. 1999 Mar;25(3):323-31. doi: 10.1016/s0886-3350(99)80079-0.
To assess the efficacy and postoperative complications of deep sclerectomy with collagen implant (DSCI), a nonpenetrating filtration procedure.
Glaucoma Unit, Department of Ophthalmology, University of Lausanne, Switzerland.
Forty-four eyes of 44 patients with medically uncontrolled open-angle glaucoma had DSCI and a matched control group of 44 patients, trabeculectomy. A superficial scleral flap was raised and a deep sclerectomy performed in the scleral bed. Schlemm's canal was opened, and the cornea was dissected to Descemet's membrane. At that stage, aqueous filtered through the remaining trabeculo-Descemet's membrane. A collagen implant was sutured radially in the scleral bed; the scleral flap and conjunctiva were then closed. Examinations were performed before surgery and postoperatively at 1 and 7 days and 1, 2, 3, 6, 9, 12, 15, 18, and 24 months.
The mean follow-up was 14.4 months +/- 6.3 (SD) (range 3 to 24 months). The mean preoperative intraoperative pressure (IOP) was 26.7 +/- 7.3 mm Hg. The mean postoperative IOP was 6.1 +/- 4.5 mm Hg at 1 day and 11.0 +/- 4.4 mm Hg at 1 week; it remained stable for the next 24 months. The success rate, defined as an IOP lower than 21.0 mm Hg without medication, was 69% in the DSCI group and 57% in the trabeculectomy group at 24 months postoperatively (P = .047). The number of postoperative complications was significantly lower in the DSCI group than in the trabeculectomy group.
The success rate of DSCI may be comparable to that of trabeculectomy, with fewer complications.
评估采用胶原植入物的深层巩膜切除术(DSCI)这一非穿透性滤过手术的疗效及术后并发症。
瑞士洛桑大学眼科青光眼科。
44例药物治疗无法控制的开角型青光眼患者的44只眼接受了DSCI手术,并设立了一个由44例患者组成的小梁切除术匹配对照组。制作一个浅层巩膜瓣,在巩膜床进行深层巩膜切除术。打开施莱姆管,将角膜剖切至后弹力层。此时,房水通过剩余的小梁-后弹力层滤过。将胶原植入物径向缝合于巩膜床;然后关闭巩膜瓣和结膜。在手术前、术后1天和7天以及1、2、3、6、9、12、15、18和24个月进行检查。
平均随访时间为14.4个月±6.3(标准差)(范围3至24个月)。术前平均眼压(IOP)为26.7±7.3 mmHg。术后1天平均IOP为6.1±4.5 mmHg,术后1周为11.0±4.4 mmHg;在接下来的24个月内保持稳定。术后24个月时,定义为无需药物治疗眼压低于21.0 mmHg的成功率,DSCI组为69%,小梁切除术组为57%(P = 0.047)。DSCI组术后并发症的数量显著低于小梁切除术组。
DSCI的成功率可能与小梁切除术相当,且并发症较少。